IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Evaluation of the Cerebral Oxygenation With Near Infrared Spectrophotometry (NIRS) at the Hypernatremic Dehydration in Newborn
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2011 by Zekai Tahir Burak Women's Health Research and Education Hospital.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Information provided by:
Zekai Tahir Burak Women's Health Research and Education Hospital
ClinicalTrials.gov Identifier:
NCT01299428
First received: February 17, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to evaluate cerebral oxygenation with Near infrared spectrophotometry (NIRS) at the hypernatremic dehydration in newborns.
| Condition | Intervention |
|---|---|
| HYPERNATREMIA | Device: INVOS 5100 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Screening |
Resource links provided by NLM:
Further study details as provided by Zekai Tahir Burak Women's Health Research and Education Hospital:
Primary Outcome Measures:
- CEREBRAL OXYGENATION [ Time Frame: 3 MONTHS ]NIRS METHODS
Secondary Outcome Measures:
- NEURODEVELOPMENT [ Time Frame: 12-18 MONTHS ]NEURODEVELOPMENT EVALUATION
| Estimated Enrollment: | 2 |
| Study Start Date: | February 2011 |
| Estimated Study Completion Date: | August 2011 |
| Estimated Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: cerebral oxygenation |
Device: INVOS 5100
INVOS 5100 IS AN EQUIPMENT THAT MEASURED CEREBRAL OXYGENATION WITH NEAR INFRARED SPECTROPHOTOMETRY METHOD.
|
Eligibility| Ages Eligible for Study: | up to 1 Month (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- gestation week > 37 ve Na >150 mg/dl
- Dehydration
Exclusion Criteria:
- Sepsis
- Intracranial Haemorrhagia
- Congenital Cardiac Diseases
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01299428
Please refer to this study by its ClinicalTrials.gov identifier: NCT01299428
Contacts
| Contact: melek akar, M.D | +905052550518 | melek_akar@yahoo.com.tr |
Locations
| Turkey | |
| Zekai Tahir Burak Maternity Teaching Hospital | Recruiting |
| Ankara, Samanpazarı, Turkey, 06460 | |
| Contact: melek akar, M.D. +905052550518 melek_akar@yahoo.com.tr | |
Sponsors and Collaborators
Zekai Tahir Burak Women's Health Research and Education Hospital
More Information
| Responsible Party: | Zekai Tahir Burak Maternity Teaching Hospital |
| ClinicalTrials.gov Identifier: | NCT01299428 History of Changes |
| Other Study ID Numbers: |
5 |
| Study First Received: | February 17, 2011 |
| Last Updated: | February 17, 2011 |
Keywords provided by Zekai Tahir Burak Women's Health Research and Education Hospital:
|
CEREBRAL OXYGENATION HYPERNATREMİA NEWBORN NA VALUES |
Additional relevant MeSH terms:
|
Hypernatremia Water-Electrolyte Imbalance Metabolic Diseases |
ClinicalTrials.gov processed this record on June 22, 2017